Home Tags ECHELON-2 trial

Tag: ECHELON-2 trial

Supplemental Biologics License Application for Brentuximab Vedotin in Frontline Treatment of...

Seattle Genetics has submitted a supplemental Biologics License Application (BLA) for brentuximab vedotin (Adcetris®) to the U.S. Food and Drug Administration (FDA).The submission is...

Positive Phase III ECHELON-1 Trial Data Leads to FDA Breakthrough Therapy...

U.S. Food and Drug Administration (FDA) has granted Breakthrough Therapy Designation to brentuximab vedotin (Adcetris®; Seattle Genetics) in combination with chemotherapy for the frontline...